Napredna pretraga

Pregled bibliografske jedinice broj: 1342

Efficacy of fluoxetine in PTSD patients


Folnegović-Šmalc, Vera; Folnegović, Zdenko; Henigsberg, Neven; Jernej, Branimir; Makarić, Gordan; Mimica, Ninoslav
Efficacy of fluoxetine in PTSD patients // Abstracts of the 6th World Congress of Biological Psychiatry ; u: Biological Psychiatry 42 (1997) (S) / Robert, P.H. ; Langer, S.Z. ; Ciprian-Ollivier, J. (ur.).
New York: Elsevier, 1997. str. 32S-32S (poster, međunarodna recenzija, sažetak, znanstveni)


Naslov
Efficacy of fluoxetine in PTSD patients

Autori
Folnegović-Šmalc, Vera ; Folnegović, Zdenko ; Henigsberg, Neven ; Jernej, Branimir ; Makarić, Gordan ; Mimica, Ninoslav

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Abstracts of the 6th World Congress of Biological Psychiatry ; u: Biological Psychiatry 42 (1997) (S) / Robert, P.H. ; Langer, S.Z. ; Ciprian-Ollivier, J. - New York : Elsevier, 1997, 32S-32S

Skup
World Congress of Biological Psychiatry (6 ; 1997)

Mjesto i datum
Nica, Francuska, 22.-27.06.1997

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
Fluoxetine; PTSD

Sažetak
This paper describes efficacy of fluoxetine in treatment of PTSD patients. A special attention is paid to particular symptoms. 46 outpatients of both sexes, aged 30-65 years with diagnosis of PTSD according to DSM IV criteria were included in a prospective, controlled trial. Fluoxetine in daily dose between 20 and 80 mg was applied for 12 weeks. The treatment response was assessed by means of HDRS, HARS, CMPTSD and CGI. The efficacy of fluoxetine was assessed each week and at the end of the trial by final evaluation of therapeutic effects. After 12 weeks in 62.8% of patients a considerable improvement was observed, in 34.9% patients improvement was minimal and status of 2.3% of patients has minimally worsened. Analysis of specific symptoms which were monitored as CMPTSD items has shown that specific smyptoms differently respond to a fluoxetine therapy. For example, in items number 1, 8, 11, 14 and 24 no statistically significant difference was observed between the beginning and the end of study. Differently, in CMPTSD items number 9, 10, 16, 20 and 21 a statistically significant difference (on 5% significance level) was observed after 12 weeks of treatment. The results are suggesting the following: (1) fluoxetine is efficient drug of cnoice in treatment of PTSD and (2) differences in therapeutic response are showing a need for additional researches aimed to more precisely define sub-categories in wxpected treatment response.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti



POVEZANOST RADA


Projekt / tema
00980002

Ustanove
Institut "Ruđer Bošković", Zagreb

Časopis indeksira:


  • Scopus
  • MEDLINE